[1]QIAO Youlin,ZHAO Yuqian.Epidemiological status and prevention of cervical cancer[J].Chinese Journal of Clinical Medicine for Women and Children (Electronic Edition),2015,11(2):1-6.[乔友林,赵宇倩.宫颈癌的流行病学现状和预防[J].中华妇幼临床医学杂志(电子版),2015,11(2):1-6.]
[2]PENG Jun,HUANG Yong.Clinical characteristics,postoperative recurrence and prognostic factors of 90 young patients with cervical cancer[J].Journal of Practical Obstetrics and Gynecology,2016,32(1):42-45.[彭俊,黄勇.90例年轻宫颈癌患者临床特征及术后复发和预后相关因素分析[J].实用妇产科杂志,2016,32(1):42-45.]
[3]Lv Q,Wu K,Liu F,et al.Interleukin 17A and heparanase promote angiogenesis and cell proliferation and invasion in cervical cancer[J].Int J Oncol,2018,26(4):114-118.
[4]SHI Yurong,LIU Jian,CHEN Sulian,et al.The effect of miR-218 on the proliferation of human cervical cancer Hela cells and its mechanism in vitro[J].China Pharmacology Bulletin,2017,33(10):1405-1409.[石玉荣,刘健,陈素莲,等.miR-218对新藤黄酸抑制人宫颈癌Hela细胞增殖作用的影响及机制研究[J].中国药理学通报,2017,33(10):1405-1409.]
[5]WU Xiaoyi,WANG Weigui,ZHENG Yingxin,et al.Analysis of clinical diagnosis and treatment of cervical carcinoma in stage Ⅰa1[J].Fudan Journal (Medical Edition),2018,45(3):330-335.[吴小肄,王维贵,郑颖馨,等.宫颈癌Ⅰa1期的临床诊治进展分析[J].复旦学报(医学版),2018,45(3):330-335.]
[6]ZHANG Bingya,WANG Tiejun,LIU Zhongshan,et al.Progress in treatment of locally advanced cervical cancer[J].Chin J Gerontol,2016,36(10):2562-2565.[张冰雅,王铁君,刘忠山,等.局部中晚期宫颈癌的治疗进展[J].中国老年学杂志,2016,36(10):2562-2565.]
[7]Boyraz G,Karalok A,Basaran D,et al.Vaginal closure with endoGIA to prevent tumor spillage in laparoscopic radical hysterectomy for cervical cancer[J].J Minim Invasive Gynecol,2018,28(4):1553-1560.
[8]LIU Jijun,ZHENG Yingying,LI Tonghui,et al.Pharmacological activity and rational use of alkaloid antitumor drugs[J].Journal of Clinical Rational Drug Use,2018,11(2):178-179.[刘吉君,郑盈盈,李同荟,等.生物碱类抗肿瘤药物的药理活性及合理用药[J].临床合理用药杂志,2018,11(2):178-179.]
[9]YANG Jincheng,JIA Bei,FEI Xiaofei,et al.Analysis on the loading of essential drugs of anti-tumor drugs in the catalogue of medical insurance in China[J].China Pharmacy,2015,26(30):4181-4184.[杨谨成,贾贝,费小非,等.我国各地医保目录中抗肿瘤药物类基本药物的收载情况分析[J].中国药房,2015,26(30):4181-4184.]
[10]DING Zhongyang,XU Fei,TANG Jiandong,et al.Effects and mechanisms of luteinic acid on proliferation,apoptosis and migration of drug-resistant gastric cancer cells[J].Shandong Medicine,2017,57(9):39-41.[丁忠阳,许飞,唐建东,等.藤黄酸对耐药胃癌细胞增殖、凋亡、迁移的影响及机制[J].山东医药,2017,57(9):39-41.]
[11]ZHANG Shengda,DING Jiewei,TANG Zhihua,et al.Chemosensitization of Hela cells by neoglyceric acid and its possible mechanism[J].Traditional Chinese Medicine,2015,38(12):2597-2601.[张生大,丁洁卫,唐志华,等.新藤黄酸对Hela细胞的化疗增敏作用及其可能机制探讨[J].中药材,2015,38(12):2597-2601.]
[12]SHI Yurong,YANG Ying.Effects and mechanisms of neoglyceric acid on proliferation,apoptosis and migration of cervical cancer Hela cells[J].Traditional Chinese Medicine,2016,39(6):1393-1398.[石玉荣,杨滢.新藤黄酸对宫颈癌Hela细胞增殖、凋亡、迁移的影响及机制研究[J].中药材,2016,39(6):1393-1398.]
[13]LIU Jun,ZHANG Xuelin,REN Yongsheng,et al.Down-regulation of BARF1 expression induces apoptosis of EBV positive gastric cancer cells through activation of caspase dependent mitochondrial pathway[J].Chin J Pathophysiol,2015,31(11):1970-1978.[刘俊,张雪林,任永生,等.BARF1表达下调通过活化caspase依赖的线粒体通路诱导EBV阳性胃癌细胞凋亡[J].中国病理生理杂志,2015,31(11):1970-1978.]
[14]JIANG Tong,JIAO Shengyuan,GAO Qiaohui,et al.Effects of radiation induced miR-1246 on epithelial mesenchymal transformation of cervical cancer Hela cells[J].Journal of Clinical Military Medicine,2018,46(4):420-423,429.[姜曈,焦胜元,高巧慧,等.辐射诱导miR-1246对宫颈癌Hela细胞上皮间质转化作用[J].临床军医杂志,2018,46(4):420-423,429.]
[15]HAN Jiang.Expression of E-cadherin and p63 protein in cervical carcinoma and their relationship with clinicopathological characteristics[J].China's Maternal and Child Health Care,2016,31(19):4048-4050.[韩江.E-cadherin和p63蛋白在宫颈癌组织中的表达及与临床病理特征的关系研究[J].中国妇幼保健,2016,31(19):4048-4050.]
[16]CHANG Lei,YUAN Yufeng,GUO Tao,et al.Expression and significance of vimentin E-cadherin in epithelial mesenchymal transformation of primary liver cancer[J].Chinese Journal of Hepatobiliary Surgery,2015,21(1):9-13.[常磊,袁玉峰,郭涛,等.波形蛋白、E-钙黏蛋白在原发性肝癌上皮间质转化过程中的表达及其意义[J].中华肝胆外科杂志,2015,21(1):9-13.]
[17]YAN Wei,XU Fanggen,LIU Anwen,et al.Effects of TLR4 on proliferation of cervical cancer cells via NF-κB signaling pathway[J].Chin J Pathophysiol,2015,31(2):301-307.[颜伟,许芳根,刘安文,等.TLR4通过NF-κB信号途径对宫颈癌细胞增殖的影响[J].中国病理生理杂志,2015,31(2):301-307.]
[18]LI Xiaofeng,CHEN Wei,LI Xu,et al.Expression and significance of EMT related genes in cervical cancer cell lines[J].Journal of Xi'an Jiaotong University (Medical Edition),2017,38(2):210-214.[李晓锋,陈葳,李旭,等.宫颈癌细胞系中EMT相关基因的表达及其意义[J].西安交通大学学报(医学版),2017,38(2):210-214.]
[19]LI Chenxi,ZHANG Zongfeng.Progression of EMT in the cervical cancer[J].Modern Oncology,2015,23(21):3204-3207.[李晨羲,张宗峰.宫颈癌中EMT相关因素的研究进展[J].现代肿瘤医学,2015,23(21):3204-3207.]
[20]ZHANG Jing.Expression of human papillomavirus 16/18 survivin in cervical carcinoma and precancerous lesions[J].China's Maternal and Child Health Care,2017,32(9):2004-2006.[张競.B淋巴细胞瘤-2、人乳头瘤病毒16/18、Survivin在宫颈癌及癌前病变中的表达特征[J].中国妇幼保健,2017,32(9):2004-2006.]